VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TDAC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TDACTranslational Development Acquisition Corp.
$10.69$234M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTDACQuarterly Financials

Translational Development Acquisition Corp. (TDAC) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Translational Development Acquisition Corp. (TDAC) quarterly income statement — complete revenue, gross profit & net income history

TDAC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q1'23Q2'22
Sales/Revenue------------
Revenue Growth %------------
Cost of Goods Sold------------
COGS % of Revenue------------
Gross Profit000000000000
Gross Margin %------------
Gross Profit Growth %------------
Operating Expenses281.16K162.34K213.66K221.13K347.41K133.39K61.28K843843483.85K6021.7K
OpEx % of Revenue------------
Selling, General & Admin281.16K162.34K213.66K221.13K347.41K133.39K61.28K843843483.85K6021.7K
SG&A % of Revenue------------
Research & Development------------
R&D % of Revenue------------
Other Operating Expenses------------
Operating Income-281.16K-162.34K-213.66K-221.13K-347.41K-133.39K-61.28K-843-843-483.85K-602-1.7K
Operating Margin %------------
Operating Income Growth %19.07%-21.71%-248.64%-26130.96%-41110.91%72.43%---40.03%---
EBITDA-281.16K-162.34K-213.66K-221.13K-347.41K-135.08K-61.28K00-483.85K00
EBITDA Margin %------------
EBITDA Growth %19.07%-20.19%-248.64%--72.08%------
D&A (Non-Cash Add-back)00000-1.69K084384306021.7K
EBIT-281.16K-162.34K-213.66K-221.13K-347.41K-133.39K-61.28K-843-843-483.85K-602-1.7K
Net Interest Income001.87M000000000
Interest Income001.87M000000000
Interest Expense000000000000
Other Income/Expense------------
Pretax Income1.33M1.6M1.66M1.62M1.48M-8.04K-61.28K-843-843-483.85K-602-1.7K
Pretax Margin %------------
Income Tax000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%
Net Income1.33M1.6M1.66M1.62M1.48M-8.04K-61.28K-843-843-483.85K-602-1.7K
Net Margin %------------
Net Income Growth %-10.13%19939.5%2808.94%192667.26%176028.11%98.34%---40.03%---
Net Income (Continuing)1.33M1.6M1.66M1.62M1.48M-8.04K-61.28K-843-843-483.85K-602-1.7K
Discontinued Operations000000000000
Minority Interest000000000000
EPS (Diluted)0.060.070.080.070.37-0.00-0.02-0.00-0.00-0.12-0.00-0.00
EPS Growth %-83.57%-629.8%--98.75%------
EPS (Basic)0.060.070.080.070.37-0.00-0.02-0.00-0.00-0.12-0.00-0.00
Diluted Shares Outstanding17.25M17.25M17.25M17.25M4.05M4.05M4.05M4.05M4.05M4.05M4.05M3.75M
Basic Shares Outstanding17.25M17.25M17.25M17.25M4.05M4.05M4.05M4.05M4.05M4.05M4.07M3.76M
Dividend Payout Ratio---113.62%--------